Synergy CHC Corp. Amortization of Debt Issuance Costs and Discounts
Synergy CHC Corp. (SNYR) reported Amortization of Debt Issuance Costs and Discounts of $951.94 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-05-14
- Synergy CHC Corp. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $951.94K, a 133.98% increase year-over-year.
- Synergy CHC Corp. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $504.98K, a 5343.37% increase year-over-year.
- Synergy CHC Corp. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $236.36K.
- Synergy CHC Corp. amortization of debt issuance costs and discounts for the quarter ending 2025-06-30 was $485.59K.
- Synergy CHC Corp. amortization of debt issuance costs and discounts for fiscal 2025 was $1.63M, a 2776.57% increase from fiscal 2024.
- Synergy CHC Corp. amortization of debt issuance costs and discounts for fiscal 2024 was $56.80K, a 16.84% increase from fiscal 2023.
- Synergy CHC Corp. amortization of debt issuance costs and discounts for fiscal 2023 was $48.61K.
- Synergy CHC Corp. amortization of debt issuance costs and discounts for fiscal 2015 was $154.53K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-03-31 | $951.94K 10-Q · filed 2026-05-14 | $1.46M derived: sum of 2 quarters · filed 2026-05-14 | $1.69M derived: sum of 3 quarters · filed 2026-05-14 | $2.18M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $504.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $741.34K derived: sum of 2 quarters · filed 2026-04-01 | $1.23M derived: sum of 3 quarters · filed 2026-04-01 | $1.63M 10-K · filed 2026-04-01 |
| 2025-09-30 | $236.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $721.95K derived: sum of 2 quarters · filed 2025-11-13 | $1.13M 10-Q · filed 2025-11-13 | $1.14M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $485.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $892.43K 10-Q · filed 2025-08-14 | $901.71K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-03-31 | $406.84K 10-Q · filed 2026-05-14 | $416.12K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $9.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $56.80K 10-K · filed 2026-04-01 | ||
| 2024-09-30 | $47.52K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $10.77K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $48.61K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $37.84K 10-Q · filed 2024-12-06 | |||
| 2015-12-31 | $53.42K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $91.17K derived: sum of 2 quarters · filed 2016-03-30 | $127.20K derived: sum of 3 quarters · filed 2016-03-30 | $154.53K 10-K · filed 2016-03-30 |
| 2015-09-30 | $37.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $73.78K derived: sum of 2 quarters · filed 2015-11-16 | $101.11K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $36.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $63.35K 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | $27.32K 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |